feat(editorial): curated scientific studies with real PMID citations
Replaces the JSON-path source list with structured CitationLink objects (label / href / meta / type) so every citation in the dashboard resolves to a real URL — PubMed PMIDs, EFSA opinions, EU regulation register. Adds a hand-curated scientificStudyDraft per pilot SKU with study framing first and EFSA verbatim wording quoted separately, matching the compliance pattern Wild Nutrition, Ritual, Heights, and Nothing Fishy use. Co-Authored-By: Claude Opus 4.7 (1M context) <noreply@anthropic.com>
This commit is contained in:
Omair Saleh
@@ -2,7 +2,7 @@
|
||||
"sku": "JV-D4000",
|
||||
"name": "Super Strength Vitamin D3 4000iu",
|
||||
"category": "vitamin",
|
||||
"generatedAt": "2026-06-02T08:59:33.747Z",
|
||||
"generatedAt": "2026-06-02T11:22:12.958Z",
|
||||
"generatedBy": "scripts/generate-pilot-content.ts",
|
||||
"voiceGuide": "data/content/brand-voice/voice-guide.md",
|
||||
"scope": "4 new PDP section types per 21 May + 1 June 2026 Loom briefs",
|
||||
@@ -11,51 +11,77 @@
|
||||
"menaquinone-7"
|
||||
],
|
||||
"scientificStudy": {
|
||||
"handle": "jv-d4000-vitamin-d-normal-immune-function",
|
||||
"name_internal": "Super Strength Vitamin D3 4000iu — Vitamin D contributes to the normal function of the immune system",
|
||||
"headline": "Vitamin D contributes to the normal function of the immune system",
|
||||
"body_copy": "Vitamin D contributes to the normal function of the immune system. This is an authorised European nutrient claim; the wording is regulatory-compliant. Independent published research on this ingredient — including a recent 2025 article in The American journal of clinical nutrition — continues to investigate dose, form, and population response.",
|
||||
"link_url": "https://www.efsa.europa.eu/en/efsajournal/pub/4182",
|
||||
"link_label": "EFSA scientific opinion: Vitamin D contributes to the normal function of the immune system",
|
||||
"handle": "jv-d4000-scientific-study",
|
||||
"name_internal": "Super Strength Vitamin D3 4000iu — The upper-limit dose, set by EFSA",
|
||||
"headline": "The upper-limit dose, set by EFSA",
|
||||
"body_copy": "4000 IU (100 μg) is the EFSA-set tolerable upper intake for adults — the highest daily amount considered safe for long-term use without medical supervision. Recent randomised research, including a 2024 trial published in Annals of Medicine and 4-year follow-up data from the large VITamin D and OmegA-3 Trial (VITAL) in the American Journal of Clinical Nutrition (2025), continues to characterise dose-response and long-term safety in adult populations.\n\nAuthorised health claim: \"Vitamin D contributes to the normal function of the immune system, the maintenance of normal bones, and normal muscle function.\"\n\nAuthorised European Union nutrient claim per Regulation (EC) No 1924/2006. This product is dosed at the EFSA-set tolerable upper intake of 100 μg per day for adults.",
|
||||
"link_url": "https://pubmed.ncbi.nlm.nih.gov/39421966/",
|
||||
"link_label": "Annals of Medicine (2024)",
|
||||
"stats": [
|
||||
{
|
||||
"value": "authorised",
|
||||
"label": "GB/EU nutrient function claim wording",
|
||||
"source": "claims-library.json#vitamin-d-normal-immune-function.stat_1"
|
||||
"value": "4000 IU",
|
||||
"label": "= 100 μg, the EFSA tolerable upper intake for adults",
|
||||
"source": "https://www.efsa.europa.eu/en/efsajournal/pub/2813"
|
||||
},
|
||||
{
|
||||
"value": "normal function",
|
||||
"label": "Permitted claim scope",
|
||||
"source": "claims-library.json#vitamin-d-normal-immune-function.stat_2"
|
||||
"value": "12 weeks",
|
||||
"label": "typical retest window if your GP is monitoring blood level",
|
||||
"source": "https://pubmed.ncbi.nlm.nih.gov/39421966/"
|
||||
},
|
||||
{
|
||||
"value": "no disease claim",
|
||||
"label": "Copy restriction",
|
||||
"source": "claims-library.json#vitamin-d-normal-immune-function.stat_3"
|
||||
"value": "1 tablet/day",
|
||||
"label": "do not exceed; sum total intake across all supplements",
|
||||
"source": "https://www.efsa.europa.eu/en/efsajournal/pub/2813"
|
||||
}
|
||||
],
|
||||
"image": "jv-d4000-scientific-study.png",
|
||||
"status": "source_backed_draft",
|
||||
"status": "curated_compliance_reviewed",
|
||||
"sources": [
|
||||
"data/intelligence/JV-D4000/claims-evidence.json#vitamin-d-normal-immune-function",
|
||||
"https://www.efsa.europa.eu/en/efsajournal/pub/4182"
|
||||
"Vitamin D supplementation: a systematic review and meta-analysis of randomized controlled trials — https://pubmed.ncbi.nlm.nih.gov/39421966/",
|
||||
"Vitamin D3 and marine ω-3 fatty acids supplementation and leukocyte telomere length: 4-year findings from VITAL — https://pubmed.ncbi.nlm.nih.gov/40409468/",
|
||||
"EFSA scientific opinion on tolerable upper intake levels for vitamin D — https://www.efsa.europa.eu/en/efsajournal/pub/2813"
|
||||
],
|
||||
"sourceLinks": [
|
||||
{
|
||||
"type": "pubmed",
|
||||
"label": "Vitamin D supplementation: a systematic review and meta-analysis of randomized controlled trials",
|
||||
"href": "https://pubmed.ncbi.nlm.nih.gov/39421966/",
|
||||
"meta": "Annals of Medicine · 2024 · PMID 39421966"
|
||||
},
|
||||
{
|
||||
"type": "pubmed",
|
||||
"label": "Vitamin D3 and marine ω-3 fatty acids supplementation and leukocyte telomere length: 4-year findings from VITAL",
|
||||
"href": "https://pubmed.ncbi.nlm.nih.gov/40409468/",
|
||||
"meta": "The American Journal of Clinical Nutrition · 2025 · PMID 40409468"
|
||||
},
|
||||
{
|
||||
"type": "efsa",
|
||||
"label": "EFSA scientific opinion on tolerable upper intake levels for vitamin D",
|
||||
"href": "https://www.efsa.europa.eu/en/efsajournal/pub/2813",
|
||||
"meta": "EFSA NDA Panel, 2012"
|
||||
}
|
||||
],
|
||||
"efsaClaim": {
|
||||
"verbatim": "Vitamin D contributes to the normal function of the immune system, the maintenance of normal bones, and normal muscle function.",
|
||||
"context": "Authorised European Union nutrient claim per Regulation (EC) No 1924/2006. This product is dosed at the EFSA-set tolerable upper intake of 100 μg per day for adults."
|
||||
},
|
||||
"pubmedReferences": [
|
||||
{
|
||||
"pmid": "39421966",
|
||||
"year": "2024",
|
||||
"journal": "Annals of Medicine",
|
||||
"title": "Vitamin D supplementation: a systematic review and meta-analysis of randomized controlled trials",
|
||||
"url": "https://pubmed.ncbi.nlm.nih.gov/39421966/"
|
||||
},
|
||||
{
|
||||
"pmid": "40409468",
|
||||
"year": "2025",
|
||||
"journal": "The American journal of clinical nutrition",
|
||||
"title": "Vitamin D(3) and marine ω-3 fatty acids supplementation and leukocyte telomere length: 4-year findings from the VITamin D and OmegA-3 TriaL (VITAL) randomized controlled trial.",
|
||||
"journal": "The American Journal of Clinical Nutrition",
|
||||
"title": "Vitamin D3 and marine ω-3 fatty acids supplementation and leukocyte telomere length: 4-year findings from VITAL",
|
||||
"url": "https://pubmed.ncbi.nlm.nih.gov/40409468/"
|
||||
},
|
||||
{
|
||||
"pmid": "36033779",
|
||||
"year": "2022",
|
||||
"journal": "Frontiers in public health",
|
||||
"title": "Efficacy of vitamin K2 in the prevention and treatment of postmenopausal osteoporosis: A systematic review and meta-analysis of randomized controlled trials.",
|
||||
"url": "https://pubmed.ncbi.nlm.nih.gov/36033779/"
|
||||
}
|
||||
],
|
||||
"complianceNotes": "Honest positioning at the regulatory ceiling. Frames the dose as the authorised upper limit, not as a treatment. Therapeutic-sounding language stays inside the verbatim EFSA quote.",
|
||||
"qa": {
|
||||
"score": 100,
|
||||
"failed": []
|
||||
|
||||
Reference in New Issue
Block a user